Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Pain
Published in: Molecular Pain 1/2013

Open Access 01-12-2013 | Review

Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel – an overview of the current mutational data

Authors: Zoltán Winter, Andrea Buhala, Ferenc Ötvös, Katalin Jósvay, Csaba Vizler, György Dombi, Gerda Szakonyi, Zoltán Oláh

Published in: Molecular Pain | Issue 1/2013

Login to get access

Abstract

This review aims to create an overview of the currently available results of site-directed mutagenesis studies on transient receptor potential vanilloid type 1 (TRPV1) receptor. Systematization of the vast number of data on the functionally important amino acid mutations of TRPV1 may provide a clearer picture of this field, and may promote a better understanding of the relationship between the structure and function of TRPV1. The review summarizes information on 112 unique mutated sites along the TRPV1, exchanged to multiple different residues in many cases. These mutations influence the effect or binding of different agonists, antagonists, and channel blockers, alter the responsiveness to heat, acid, and voltage dependence, affect the channel pore characteristics, and influence the regulation of the receptor function by phosphorylation, glycosylation, calmodulin, PIP2, ATP, and lipid binding. The main goal of this paper is to publish the above mentioned data in a form that facilitates in silico molecular modelling of the receptor by promoting easier establishment of boundary conditions. The better understanding of the structure-function relationship of TRPV1 may promote discovery of new, promising, more effective and safe drugs for treatment of neurogenic inflammation and pain-related diseases and may offer new opportunities for therapeutic interventions.
Appendix
Available only for authorised users
Literature
1.
Carlson AE, Westenbroek RE, Quill T, Ren D, Clapham DE, Hille B, Garbers DL, Babcock DF: CatSper1 required for evoked Ca2+ entry and control of flagellar function in sperm. Proc Natl Acad Sci U S A 2003, 100: 14864–14868. 10.1073/pnas.2536658100PubMedCentralPubMedCrossRef
2.
Cosens DJ, Manning A: Abnormal electroretinogram from a Drosophila mutant. Nature 1969, 224: 285–287. 10.1038/224285a0PubMedCrossRef
3.
O'Neill J, Brock C, Olesen AE, Andresen T, Nilsson M, Dickenson AH: Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev 2012, 64: 939–971. 10.1124/pr.112.006163PubMedCentralPubMedCrossRef
4.
5.
Owsianik G, Talavera K, Voets T, Nilius B: Permeation and selectivity of TRP channels. Annu Rev Physiol 2006, 68: 685–717. 10.1146/annurev.physiol.68.040204.101406PubMedCrossRef
6.
7.
Landry Y, Gies JP: Drugs and their molecular targets: an updated overview. Fundam Clin Pharmacol 2008, 22: 1–18.PubMedCrossRef
8.
Okuhara DY, Hsia AY, Xie M: Transient receptor potential channels as drug targets. Expert Opin Ther Targets 2007, 11: 391–401. 10.1517/14728222.11.3.391PubMedCrossRef
9.
Szallasi A, Cortright DN, Blum CA, Eid SR: The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007, 6: 357–372. 10.1038/nrd2280PubMedCrossRef
10.
Nilius B, Vennekens R: Gomtsyan A, Faltynek CR. In Vanilloid Receptor TRPV1 in Drug Discovery: Targeting Pain and Other Pathological Disorders. Hoboken, NJ, USA: John Wiley & Sons, Inc; 2010.
11.
Xu SZ, Zeng F, Boulay G, Grimm C, Harteneck C, Beech DJ: Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br J Pharmacol 2005, 145: 405–414.PubMedCentralPubMedCrossRef
12.
Jin X, Touhey J, Gaudet R: Structure of the N-terminal ankyrin repeat domain of the TRPV2 ion channel. J Biol Chem 2006, 281: 25006–25010. 10.1074/jbc.C600153200PubMedCrossRef
13.
McCleverty CJ, Koesema E, Patapoutian A, Lesley SA, Kreusch A: Crystal structure of the human TRPV2 channel ankyrin repeat domain. Protein Sci 2006, 15: 2201–2206. 10.1110/ps.062357206PubMedCentralPubMedCrossRef
14.
Lishko PV, Procko E, Jin X, Phelps CB, Gaudet R: The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. Neuron 2007, 54: 905–918. 10.1016/j.neuron.2007.05.027PubMedCrossRef
15.
Hellwig N, Albrecht N, Harteneck C, Schultz G, Schaefer M: Homo- and heteromeric assembly of TRPV channel subunits. J Cell Sci 2005, 118: 917–928. 10.1242/jcs.01675PubMedCrossRef
16.
Jung J, Lee SY, Hwang SW, Cho H, Shin J, Kang YS, Kim S, Oh U: Agonist recognition sites in the cytosolic tails of vanilloid receptor 1. J Biol Chem 2002, 277: 44448–44454. 10.1074/jbc.M207103200PubMedCrossRef
17.
Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY: The ankyrin repeat as molecular architecture for protein recognition. Protein Sci 2004, 13: 1435–1448. 10.1110/ps.03554604PubMedCentralPubMedCrossRef
18.
Sedgwick SG, Smerdon SJ: The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci 1999, 24: 311–316. 10.1016/S0968-0004(99)01426-7PubMedCrossRef
19.
Vennekens R, Hoenderop JG, Prenen J, Stuiver M, Willems PH, Droogmans G, Nilius B, Bindels RJ: Permeation and gating properties of the novel epithelial Ca(2+) channel. J Biol Chem 2000, 275: 3963–3969. 10.1074/jbc.275.6.3963PubMedCrossRef
20.
Yue L, Peng JB, Hediger MA, Clapham DE: CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature 2001, 410: 705–709. 10.1038/35070596PubMedCrossRef
21.
Dhaka A, Viswanath V, Patapoutian A: Trp ion channels and temperature sensation. Annu Rev Neurosci 2006, 29: 135–161. 10.1146/annurev.neuro.29.051605.112958PubMedCrossRef
22.
Lawson JJ, McIlwrath SL, Woodbury CJ, Davis BM, Koerber HR: TRPV1 unlike TRPV2 is restricted to a subset of mechanically insensitive cutaneous nociceptors responding to heat. J Pain 2008, 9: 298–308. 10.1016/j.jpain.2007.12.001PubMedCentralPubMedCrossRef
23.
Xu H, Delling M, Jun JC, Clapham DE: Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci 2006, 9: 628–635. 10.1038/nn1692PubMedCrossRef
24.
Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, Andahazy M, Story GM, Patapoutian A: Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 2005, 307: 1468–1472. 10.1126/science.1108609PubMedCrossRef
25.
Nilius B, Owsianik G, Voets T, Peters JA: Transient receptor potential cation channels in disease. Physiol Rev 2007, 87: 165–217. 10.1152/physrev.00021.2006PubMedCrossRef
26.
Hoenderop JG, van der Kemp AW, Hartog A, van de Graaf SF, van Os CH, Willems PH, Bindels RJ: Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 1999, 274: 8375–8378. 10.1074/jbc.274.13.8375PubMedCrossRef
27.
Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA: Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 1999, 274: 22739–22746. 10.1074/jbc.274.32.22739PubMedCrossRef
28.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389: 816–824. 10.1038/39807PubMedCrossRef
29.
Kedei N, Szabo T, Lile JD, Treanor JJ, Olah Z, Iadarola MJ, Blumberg PM: Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem 2001, 276: 28613–28619. 10.1074/jbc.M103272200PubMedCrossRef
30.
Moiseenkova-Bell VY, Stanciu LA: Serysheva, II, Tobe BJ, Wensel TG: Structure of TRPV1 channel revealed by electron cryomicroscopy. Proc Natl Acad Sci U S A 2008, 105: 7451–7455. 10.1073/pnas.0711835105PubMedCentralPubMedCrossRef
31.
Vriens J, Appendino G, Nilius B: Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol 2009, 75: 1262–1279. 10.1124/mol.109.055624PubMedCrossRef
32.
Szallasi A, Blumberg PM: Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989, 30: 515–520. 10.1016/0306-4522(89)90269-8PubMedCrossRef
33.
Latorre R, Brauchi S, Orta G, Zaelzer C, Vargas G: ThermoTRP channels as modular proteins with allosteric gating. Cell Calcium 2007, 42: 427–438. 10.1016/j.ceca.2007.04.004PubMedCrossRef
34.
Szallasi A: The vanilloid (capsaicin) receptor: receptor types and species differences. Gen Pharmacol 1994, 25: 223–243. 10.1016/0306-3623(94)90049-3PubMedCrossRef
35.
Witte DG, Cassar SC, Masters JN, Esbenshade T, Hancock AA: Use of a fluorescent imaging plate reader–based calcium assay to assess pharmacological differences between the human and rat vanilloid receptor. J Biomol Screen 2002, 7: 466–475. 10.1177/108705702237679PubMedCrossRef
36.
Culshaw AJ, Bevan S, Christiansen M, Copp P, Davis A, Davis C, Dyson A, Dziadulewicz EK, Edwards L, Eggelte H, et al.: Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain. J Med Chem 2006, 49: 471–474. 10.1021/jm051058xPubMedCrossRef
37.
Pearce LV, Petukhov PA, Szabo T, Kedei N, Bizik F, Kozikowski AP, Blumberg PM: Evodiamine functions as an agonist for the vanilloid receptor TRPV1. Org Biomol Chem 2004, 2: 2281–2286. 10.1039/b404506hPubMedCrossRef
38.
Xu S, Cheng Y, Keast JR, Osborne PB: 17beta-estradiol activates estrogen receptor beta-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons. Endocrinology 2008, 149: 5540–5548. 10.1210/en.2008-0278PubMedCentralPubMedCrossRef
39.
De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V: Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 2000, 483: 52–56. 10.1016/S0014-5793(00)02082-2PubMedCrossRef
40.
41.
Ahern GP: Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 2003, 278: 30429–30434. 10.1074/jbc.M305051200PubMedCrossRef
42.
Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, Oh U: Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A 2000, 97: 6155–6160. 10.1073/pnas.97.11.6155PubMedCentralPubMedCrossRef
43.
Jordt SE, Tominaga M, Julius D: Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci U S A 2000, 97: 8134–8139. 10.1073/pnas.100129497PubMedCentralPubMedCrossRef
44.
Szallasi A, Blumberg PM: Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51: 159–212.PubMed
45.
Yang BH, Piao ZG, Kim YB, Lee CH, Lee JK, Park K, Kim JS, Oh SB: Activation of vanilloid receptor 1 (VR1) by eugenol. J Dent Res 2003, 82: 781–785. 10.1177/154405910308201004PubMedCrossRef
46.
47.
Premkumar LS, Qi ZH, Van Buren J, Raisinghani M: Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor. J Neurophysiol 2004, 91: 1442–1449.PubMedCrossRef
48.
Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM: Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 2004, 141: 1118–1130. 10.1038/sj.bjp.0705711PubMedCentralPubMedCrossRef
49.
Suh YG, Oh U: Activation and activators of TRPV1 and their pharmaceutical implication. Curr Pharm Des 2005, 11: 2687–2698. 10.2174/1381612054546789PubMedCrossRef
50.
Liu L, Simon SA: Similarities and differences in the currents activated by capsaicin, piperine, and zingerone in rat trigeminal ganglion cells. J Neurophysiol 1996, 76: 1858–1869.PubMed
51.
McNamara FN, Randall A, Gunthorpe MJ: Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol 2005, 144: 781–790. 10.1038/sj.bjp.0706040PubMedCentralPubMedCrossRef
52.
Dedov VN, Tran VH, Duke CC, Connor M, Christie MJ, Mandadi S, Roufogalis BD: Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol 2002, 137: 793–798. 10.1038/sj.bjp.0704925PubMedCentralPubMedCrossRef
53.
Iwasaki Y, Morita A, Iwasawa T, Kobata K, Sekiwa Y, Morimitsu Y, Kubota K, Watanabe T: A nonpungent component of steamed ginger–[10]-shogaol–increases adrenaline secretion via the activation of TRPV1. Nutr Neurosci 2006, 9: 169–178. 10.1080/10284150600955164PubMedCrossRef
54.
Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, Kim D, Oh U: Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 1999, 19: 529–538.PubMed
55.
Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ, Peppiatt CM: 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J 2002, 16: 1145–1150. 10.1096/fj.02-0037revPubMedCrossRef
56.
Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum AI, Julius D: TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006, 124: 1269–1282. 10.1016/j.cell.2006.02.023PubMedCrossRef
57.
Macpherson LJ, Geierstanger BH, Viswanath V, Bandell M, Eid SR, Hwang S, Patapoutian A: The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr Biol 2005, 15: 929–934. 10.1016/j.cub.2005.04.018PubMedCrossRef
58.
Everaerts W, Gees M, Alpizar YA, Farre R, Leten C, Apetrei A, Dewachter I, van Leuven F, Vennekens R, De Ridder D, et al.: The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil. Curr Biol 2011, 21: 316–321. 10.1016/j.cub.2011.01.031PubMedCrossRef
59.
Mori N, Kawabata F, Matsumura S, Hosokawa H, Kobayashi S, Inoue K, Fushiki T: Intragastric administration of allyl isothiocyanate increases carbohydrate oxidation via TRPV1 but not TRPA1 in mice. Am J Physiol Regul Integr Comp Physiol 2011, 300: R1494–1505. 10.1152/ajpregu.00645.2009PubMedCrossRef
60.
Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, Patapoutian A: Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41: 849–857. 10.1016/S0896-6273(04)00150-3PubMedCrossRef
61.
Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, et al.: ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 2003, 112: 819–829. 10.1016/S0092-8674(03)00158-2PubMedCrossRef
62.
Bautista DM, Movahed P, Hinman A, Axelsson HE, Sterner O, Hogestatt ED, Julius D, Jordt SE, Zygmunt PM: Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci U S A 2005, 102: 12248–12252. 10.1073/pnas.0505356102PubMedCentralPubMedCrossRef
63.
Pecze L, Pelsoczi P, Kecskes M, Winter Z, Papp A, Kaszas K, Letoha T, Vizler C, Olah Z: Resiniferatoxin mediated ablation of TRPV1+ neurons removes TRPA1 as well. Can J Neurol Sci 2009, 36: 234–241.PubMedCrossRef
64.
Szolcsanyi J, Sandor Z: Multisteric TRPV1 nocisensor: a target for analgesics. Trends Pharmacol Sci 2012, 33: 646–655. 10.1016/j.tips.2012.09.002PubMedCrossRef
65.
Dray A, Bettaney J, Forster P: Resiniferatoxin, a potent capsaicin-like stimulator of peripheral nociceptors in the neonatal rat tail in vitro. Br J Pharmacol 1990, 99: 323–326. 10.1111/j.1476-5381.1990.tb14702.xPubMedCentralPubMedCrossRef
66.
Docherty RJ, Yeats JC, Piper AS: Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. Br J Pharmacol 1997, 121: 1461–1467. 10.1038/sj.bjp.0701272PubMedCentralPubMedCrossRef
67.
Liu L, Simon SA: Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. Neurosci Lett 1997, 228: 29–32. 10.1016/S0304-3940(97)00358-3PubMedCrossRef
68.
Xia R, Dekermendjian K, Lullau E, Dekker N: TRPV1: a therapy target that attracts the pharmaceutical interests. Adv Exp Med Biol 2011, 704: 637–665. 10.1007/978-94-007-0265-3_34PubMedCrossRef
69.
Seabrook GR, Sutton KG, Jarolimek W, Hollingworth GJ, Teague S, Webb J, Clark N, Boyce S, Kerby J, Ali Z, et al.: Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin. J Pharmacol Exp Ther 2002, 303: 1052–1060. 10.1124/jpet.102.040394PubMedCrossRef
70.
Planells-Cases R, Aracil A, Merino JM, Gallar J, Perez-Paya E, Belmonte C, Gonzalez-Ros JM, Ferrer-Montiel AV: Arginine-rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett 2000, 481: 131–136. 10.1016/S0014-5793(00)01982-7PubMedCrossRef
71.
Himmel HM, Kiss T, Borvendeg SJ, Gillen C, Illes P: The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons. J Pharmacol Exp Ther 2002, 301: 981–986. 10.1124/jpet.301.3.981PubMedCrossRef
72.
Gavva NR: Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci 2008, 29: 550–557. 10.1016/j.tips.2008.08.003PubMedCrossRef
73.
Gavva NR, Bannon AW, Surapaneni S, Hovland DN Jr, Lehto SG, Gore A, Juan T, Deng H, Han B, Klionsky L, et al.: The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci 2007, 27: 3366–3374. 10.1523/JNEUROSCI.4833-06.2007PubMedCrossRef
74.
Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S, Akrami A, Alvarez F, Bak A, Darling M, Gore A, et al.: Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 2008, 136: 202–210. 10.1016/j.pain.2008.01.024PubMedCrossRef
75.
Wang S, Poon K, Oswald RE, Chuang HH: Distinct modulations of human capsaicin receptor by protons and magnesium through different domains. J Biol Chem 2010, 285: 11547–11556. 10.1074/jbc.M109.058727PubMedCentralPubMedCrossRef
76.
Voets T, Droogmans G, Wissenbach U, Janssens A, Flockerzi V, Nilius B: The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 2004, 430: 748–754. 10.1038/nature02732PubMedCrossRef
77.
Ma W, Quirion R: Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 2007, 11: 307–320. 10.1517/14728222.11.3.307PubMedCrossRef
78.
79.
Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D: The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21: 531–543. 10.1016/S0896-6273(00)80564-4PubMedCrossRef
80.
Olah Z, Szabo T, Karai L, Hough C, Fields RD, Caudle RM, Blumberg PM, Iadarola MJ: Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem 2001, 276: 11021–11030. 10.1074/jbc.M008392200PubMedCrossRef
81.
Sprague J, Harrison C, Rowbotham DJ, Smart D, Lambert DG: Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. Eur J Pharmacol 2001, 423: 121–125. 10.1016/S0014-2999(01)01123-2PubMedCrossRef
82.
De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V: The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 2001, 77: 1660–1663. 10.1046/j.1471-4159.2001.00406.xPubMedCrossRef
83.
Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang SY, Nau C, Kress M: PKA/AKAP/VR-1 module: A common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 2002, 22: 4740–4745.PubMed
84.
Vlachova V, Teisinger J, Susankova K, Lyfenko A, Ettrich R, Vyklicky L: Functional role of C-terminal cytoplasmic tail of rat vanilloid receptor 1. J Neurosci 2003, 23: 1340–1350.PubMed
85.
Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS: Gereau RWt: Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci U S A 2003, 100: 12480–12485. 10.1073/pnas.2032100100PubMedCentralPubMedCrossRef
86.
Zhang X, Du XN, Zhang GH, Jia ZF, Chen XJ, Huang DY, Liu BY, Zhang HL: Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives. Mol Pharmacol 2012, 81: 689–700. 10.1124/mol.111.076000PubMedCrossRef
87.
Ohta T, Imagawa T, Ito S: Novel agonistic action of mustard oil on recombinant and endogenous porcine transient receptor potential V1 (pTRPV1) channels. Biochem Pharmacol 2007, 73: 1646–1656. 10.1016/j.bcp.2007.01.029PubMedCrossRef
88.
Czaja K, Burns GA, Ritter RC: Capsaicin-induced neuronal death and proliferation of the primary sensory neurons located in the nodose ganglia of adult rats. Neuroscience 2008, 154: 621–630. 10.1016/j.neuroscience.2008.03.055PubMedCentralPubMedCrossRef
89.
Olah Z, Karai L, Iadarola MJ: Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways. J Biol Chem 2002, 277: 35752–35759. 10.1074/jbc.M201551200PubMedCrossRef
90.
Wang Y, Kedei N, Wang M, Wang QJ, Huppler AR, Toth A, Tran R, Blumberg PM: Interaction between protein kinase Cmu and the vanilloid receptor type 1. J Biol Chem 2004, 279: 53674–53682. 10.1074/jbc.M410331200PubMedCrossRef
91.
Jung J, Shin JS, Lee SY, Hwang SW, Koo J, Cho H, Oh U: Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding. J Biol Chem 2004, 279: 7048–7054.PubMedCrossRef
92.
Zhou HY, Zhang HM, Chen SR, Pan HL: Increased nociceptive input rapidly modulates spinal GABAergic transmission through endogenously released glutamate. J Neurophysiol 2007, 97: 871–882. 10.1152/jn.00964.2006PubMedCrossRef
93.
Docherty RJ, Yeats JC, Bevan S, Boddeke HW: Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Arch 1996, 431: 828–837.PubMedCrossRef
94.
Koplas PA, Rosenberg RL, Oxford GS: The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J Neurosci 1997, 17: 3525–3537.PubMed
95.
Prescott ED, Julius D: A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 2003, 300: 1284–1288. 10.1126/science.1083646PubMedCrossRef
96.
Liu B, Zhang C, Qin F: Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. J Neurosci 2005, 25: 4835–4843. 10.1523/JNEUROSCI.1296-05.2005PubMedCrossRef
97.
Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE: Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 2006, 128: 509–522. 10.1085/jgp.200609576PubMedCentralPubMedCrossRef
98.
Ufret-Vincenty CA, Klein RM, Hua L, Angueyra J, Gordon SE: Localization of the PIP2 sensor of TRPV1 ion channels. J Biol Chem 2011, 286: 9688–9698. 10.1074/jbc.M110.192526PubMedCentralPubMedCrossRef
99.
Yao J, Qin F: Interaction with phosphoinositides confers adaptation onto the TRPV1 pain receptor. PLoS Biol 2009, 7: e46. 10.1371/journal.pbio.1000046PubMedCrossRef
100.
101.
Levitan I, Christian AE, Tulenko TN, Rothblat GH: Membrane cholesterol content modulates activation of volume-regulated anion current in bovine endothelial cells. J Gen Physiol 2000, 115: 405–416. 10.1085/jgp.115.4.405PubMedCentralPubMedCrossRef
102.
103.
Liu M, Huang W, Wu D, Priestley JV: TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors. Eur J Neurosci 2006, 24: 1–6. 10.1111/j.1460-9568.2006.04889.xPubMedCrossRef
104.
Szoke E, Borzsei R, Toth DM, Lengl O, Helyes Z, Sandor Z, Szolcsanyi J: Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line. Eur J Pharmacol 2010, 628: 67–74. 10.1016/j.ejphar.2009.11.052PubMedCrossRef
105.
Santha P, Oszlacs O, Dux M, Dobos I, Jancso G: Inhibition of glucosylceramide synthase reversibly decreases the capsaicin-induced activation and TRPV1 expression of cultured dorsal root ganglion neurons. Pain 2010, 150: 103–112. 10.1016/j.pain.2010.04.006PubMedCrossRef
106.
Numazaki M, Tominaga T, Takeuchi K, Murayama N, Toyooka H, Tominaga M: Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc Natl Acad Sci U S A 2003, 100: 8002–8006. 10.1073/pnas.1337252100PubMedCentralPubMedCrossRef
107.
108.
Vyklicky L, Novakova-Tousova K, Benedikt J, Samad A, Touska F, Vlachova V: Calcium-dependent desensitization of vanilloid receptor TRPV1: a mechanism possibly involved in analgesia induced by topical application of capsaicin. Physiol Res 2008, 57(Suppl 3):S59–68.PubMed
109.
Tominaga M, Wada M, Masu M: Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci U S A 2001, 98: 6951–6956. 10.1073/pnas.111025298PubMedCentralPubMedCrossRef
110.
Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA: Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol 2001, 534: 813–825. 10.1111/j.1469-7793.2001.00813.xPubMedCentralPubMedCrossRef
111.
Farkas B, Bonnekoh B, Mahrle G: Repeated treatment with dithranol induces a tolerance reaction in keratinocytes in vitro. Arch Dermatol Res 1991, 283: 337–341. 10.1007/BF00376624PubMedCrossRef
112.
Susankova K, Tousova K, Vyklicky L, Teisinger J, Vlachova V: Reducing and oxidizing agents sensitize heat-activated vanilloid receptor (TRPV1) current. Mol Pharmacol 2006, 70: 383–394.PubMed
113.
Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA: Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 1999, 23: 617–624. 10.1016/S0896-6273(00)80813-2PubMedCrossRef
114.
Premkumar LS, Ahern GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000, 408: 985–990. 10.1038/35050121PubMedCrossRef
115.
Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D: Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001, 411: 957–962. 10.1038/35082088PubMedCrossRef
116.
Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS: Gereau RWt: cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35: 721–731. 10.1016/S0896-6273(02)00802-4PubMedCrossRef
117.
Shin HJ, Gye MH, Chung KH, Yoo BS: Activity of protein kinase C modulates the apoptosis induced by polychlorinated biphenyls in human leukemic HL-60 cells. Toxicol Lett 2002, 135: 25–31. 10.1016/S0378-4274(02)00231-XPubMedCrossRef
118.
Bevan S, Andersson DA: TRP channel antagonists for pain–opportunities beyond TRPV1. Curr Opin Investig Drugs 2009, 10: 655–663.PubMed
119.
Cortright DN, Szallasi A: TRP channels and pain. Curr Pharm Des 2009, 15: 1736–1749. 10.2174/138161209788186308PubMedCrossRef
120.
Stucky CL, Dubin AE, Jeske NA, Malin SA, McKemy DD, Story GM: Roles of transient receptor potential channels in pain. Brain Res Rev 2009, 60: 2–23. 10.1016/j.brainresrev.2008.12.018PubMedCentralPubMedCrossRef
121.
Fernandes ES, Russell FA, Spina D, McDougall JJ, Graepel R, Gentry C, Staniland AA, Mountford DM, Keeble JE, Malcangio M, et al.: A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor alpha-induced inflammatory hyperalgesia and Freund's complete adjuvant-induced monarthritis. Arthritis Rheum 2011, 63: 819–829. 10.1002/art.30150PubMedCrossRef
122.
Fernandes ES, Fernandes MA, Keeble JE: The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 2012, 166: 510–521. 10.1111/j.1476-5381.2012.01851.xPubMedCentralPubMedCrossRef
123.
Alawi K, Keeble J: The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 2010, 125: 181–195. 10.1016/j.pharmthera.2009.10.005PubMedCrossRef
124.
Dux M, Santha P, Jancso G: The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches. Pflugers Arch 2012, 464: 239–248. 10.1007/s00424-012-1142-7PubMedCrossRef
125.
Jin K, Xie L, Kim SH, Parmentier-Batteur S, Sun Y, Mao XO, Childs J, Greenberg DA: Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol 2004, 66: 204–208. 10.1124/mol.66.2.204PubMedCrossRef
126.
Jancso-Gabor A, Szolcsanyi J, Jancso N: Stimulation and desensitization of the hypothalamic heat-sensitive structures by capsaicin in rats. J Physiol 1970, 208: 449–459.PubMedCentralPubMedCrossRef
127.
Jancso G, Wollemann M: The effect of capsaicin on the adenylate cyclase activity of rat brain. Brain Res 1977, 123: 323–329. 10.1016/0006-8993(77)90483-8PubMedCrossRef
128.
Dib B: Effects of intracerebroventricular capsaicin on thermoregulatory behavior in the rat. Pharmacol Biochem Behav 1982, 16: 23–27. 10.1016/0091-3057(82)90007-7PubMedCrossRef
129.
Steiner AA, Turek VF, Almeida MC, Burmeister JJ, Oliveira DL, Roberts JL, Bannon AW, Norman MH, Louis JC, Treanor JJ, et al.: Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci 2007, 27: 7459–7468. 10.1523/JNEUROSCI.1483-07.2007PubMedCrossRef
130.
Gavva NR, Bannon AW, Hovland DN Jr, Lehto SG, Klionsky L, Surapaneni S, Immke DC, Henley C, Arik L, Bak A, et al.: Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther 2007, 323: 128–137. 10.1124/jpet.107.125674PubMedCrossRef
131.
Tamayo N, Liao H, Stec MM, Wang X, Chakrabarti P, Retz D, Doherty EM, Surapaneni S, Tamir R, Bannon AW, et al.: Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists. J Med Chem 2008, 51: 2744–2757. 10.1021/jm7014638PubMedCrossRef
132.
Inoue K, Koizumi S, Fuziwara S, Denda S, Denda M: Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem Biophys Res Commun 2002, 291: 124–129. 10.1006/bbrc.2002.6393PubMedCrossRef
133.
Kim SJ, Lee SA, Yun SJ, Kim JK, Park JS, Jeong HS, Lee JH, Moon SJ, Won YH: Expression of vanilloid receptor 1 in cultured fibroblast. Exp Dermatol 2006, 15: 362–367. 10.1111/j.0906-6705.2006.00418.xPubMedCrossRef
134.
Grone A, Fonfara S, Baumgartner W: Cell type-dependent cytokine expression after canine distemper virus infection. Viral Immunol 2002, 15: 493–505. 10.1089/088282402760312368PubMedCrossRef
135.
Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB: Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003, 304: 217–222. 10.1124/jpet.102.040675PubMedCrossRef
136.
Saunders CI, Kunde DA, Crawford A, Geraghty DP: Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. Mol Immunol 2007, 44: 1429–1435. 10.1016/j.molimm.2006.04.027PubMedCrossRef
137.
Basu S, Srivastava P: Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc Natl Acad Sci U S A 2005, 102: 5120–5125. 10.1073/pnas.0407780102PubMedCentralPubMedCrossRef
138.
Geppetti P, Nassini R, Materazzi S, Benemei S: The concept of neurogenic inflammation. BJU Int 2008, 101(Suppl 3):2–6.PubMedCrossRef
139.
Earley S, Gonzales AL, Crnich R: Endothelium-dependent cerebral artery dilation mediated by TRPA1 and Ca2+−Activated K+ channels. Circ Res 2009, 104: 987–994. 10.1161/CIRCRESAHA.108.189530PubMedCentralPubMedCrossRef
140.
Kark T, Bagi Z, Lizanecz E, Pasztor ET, Erdei N, Czikora A, Papp Z, Edes I, Porszasz R, Toth A: Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1. Mol Pharmacol 2008, 73: 1405–1412. 10.1124/mol.107.043323PubMedCrossRef
141.
Luo D, Zhang YW, Peng WJ, Peng J, Chen QQ, Li D, Deng HW, Li YJ: Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide. Regul Pept 2008, 150: 66–72. 10.1016/j.regpep.2008.05.007PubMedCrossRef
142.
Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I: Calcitonin gene-related peptide is a potent vasodilator. Nature 1985, 313: 54–56. 10.1038/313054a0PubMedCrossRef
143.
Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400: 452–457. 10.1038/22761PubMedCrossRef
144.
Keeble JE, Brain SD: Capsaicin-induced vasoconstriction in the mouse knee joint: a study using TRPV1 knockout mice. Neurosci Lett 2006, 401: 55–58. 10.1016/j.neulet.2006.02.083PubMedCrossRef
145.
Cavanaugh DJ, Chesler AT, Jackson AC, Sigal YM, Yamanaka H, Grant R, O'Donnell D, Nicoll RA, Shah NM, Julius D, Basbaum AI: Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 2011, 31: 5067–5077. 10.1523/JNEUROSCI.6451-10.2011PubMedCentralPubMedCrossRef
146.
Dux M, Santha P, Jancso G: Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J Physiol 2003, 552: 859–867. 10.1113/jphysiol.2003.050633PubMedCentralPubMedCrossRef
147.
Wang YX, Wang J, Wang C, Liu J, Shi LP, Xu M: Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells. J Membr Biol 2008, 223: 151–159. 10.1007/s00232-008-9121-9PubMedCrossRef
148.
Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ: Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005, 338: 694–699. 10.1016/j.bbrc.2005.09.195PubMedCrossRef
149.
Hsu CL, Yen GC: Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J Agric Food Chem 2007, 55: 1730–1736. 10.1021/jf062912bPubMedCrossRef
150.
Zhang LL, Yan Liu D, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, et al.: Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 2007, 100: 1063–1070. 10.1161/01.RES.0000262653.84850.8bPubMedCrossRef
151.
Ohnuki K, Haramizu S, Oki K, Watanabe T, Yazawa S, Fushiki T: Administration of capsiate, a non-pungent capsaicin analog, promotes energy metabolism and suppresses body fat accumulation in mice. Biosci Biotechnol Biochem 2001, 65: 2735–2740. 10.1271/bbb.65.2735PubMedCrossRef
152.
Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R: Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity (Silver Spring) 2010, 18: 780–787. 10.1038/oby.2009.301CrossRef
153.
Romanovsky AA, Almeida MC, Garami A, Steiner AA, Norman MH, Morrison SF, Nakamura K, Burmeister JJ, Nucci TB: The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev 2009, 61: 228–261. 10.1124/pr.109.001263PubMedCentralPubMedCrossRef
154.
Caterina MJ: Transient receptor potential ion channels as participants in thermosensation and thermoregulation. Am J Physiol Regul Integr Comp Physiol 2007, 292: R64–76.PubMedCrossRef
155.
Masamoto Y, Kawabata F, Fushiki T: Intragastric administration of TRPV1, TRPV3, TRPM8, and TRPA1 agonists modulates autonomic thermoregulation in different manners in mice. Biosci Biotechnol Biochem 2009, 73: 1021–1027. 10.1271/bbb.80796PubMedCrossRef
156.
Kawabata F, Inoue N, Masamoto Y, Matsumura S, Kimura W, Kadowaki M, Higashi T, Tominaga M, Inoue K, Fushiki T: Non-pungent capsaicin analogs (capsinoids) increase metabolic rate and enhance thermogenesis via gastrointestinal TRPV1 in mice. Biosci Biotechnol Biochem 2009, 73: 2690–2697. 10.1271/bbb.90555PubMedCrossRef
157.
Toth DM, Szoke E, Bolcskei K, Kvell K, Bender B, Bosze Z, Szolcsanyi J, Sandor Z: Nociception, neurogenic inflammation and thermoregulation in TRPV1 knockdown transgenic mice. Cell Mol Life Sci 2011, 68: 2589–2601. 10.1007/s00018-010-0569-2PubMedCrossRef
158.
Bodo E, Biro T, Telek A, Czifra G, Griger Z, Toth BI, Mescalchin A, Ito T, Bettermann A, Kovacs L, Paus R: A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 2005, 166: 985–998. 10.1016/S0002-9440(10)62320-6PubMedCentralPubMedCrossRef
159.
White JP, Urban L, Nagy I: TRPV1 function in health and disease. Curr Pharm Biotechnol 2011, 12: 130–144. 10.2174/138920111793937844PubMedCrossRef
160.
Cortright DN, Krause JE, Broom DC: TRP channels and pain. Biochim Biophys Acta 2007, 1772: 978–988. 10.1016/j.bbadis.2007.03.003PubMedCrossRef
161.
Gunthorpe MJ, Szallasi A: Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharm Des 2008, 14: 32–41. 10.2174/138161208783330754PubMedCrossRef
162.
Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, Papp Z, Edes I, Csiba L, Blumberg PM: Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 2005, 135: 162–168. 10.1016/j.molbrainres.2004.12.003PubMedCrossRef
163.
Yiangou Y, Facer P, Dyer NH, Chan CL, Knowles C, Williams NS, Anand P: Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001, 357: 1338–1339. 10.1016/S0140-6736(00)04503-7PubMedCrossRef
164.
Chan CL, Facer P, Davis JB, Smith GD, Egerton J, Bountra C, Williams NS, Anand P: Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003, 361: 385–391. 10.1016/S0140-6736(03)12392-6PubMedCrossRef
165.
Welch JM, Simon SA, Reinhart PH: The activation mechanism of rat vanilloid receptor 1 by capsaicin involves the pore domain and differs from the activation by either acid or heat. Proc Natl Acad Sci U S A 2000, 97: 13889–13894. 10.1073/pnas.230146497PubMedCentralPubMedCrossRef
166.
Kuzhikandathil EV, Wang H, Szabo T, Morozova N, Blumberg PM, Oxford GS: Functional analysis of capsaicin receptor (vanilloid receptor subtype 1) multimerization and agonist responsiveness using a dominant negative mutation. J Neurosci 2001, 21: 8697–8706.PubMed
167.
Grandl J, Kim SE, Uzzell V, Bursulaya B, Petrus M, Bandell M, Patapoutian A: Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain. Nat Neurosci 2010, 13: 708–714. 10.1038/nn.2552PubMedCentralPubMedCrossRef
168.
Jordt SE, Julius D: Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 2002, 108: 421–430. 10.1016/S0092-8674(02)00637-2PubMedCrossRef
169.
Ho KW, Ward NJ, Calkins DJ: TRPV1: a stress response protein in the central nervous system. Am J Neurodegener Dis 2012, 1: 1–14.PubMedCentralPubMed
170.
Chou MZ, Mtui T, Gao YD, Kohler M, Middleton RE: Resiniferatoxin binds to the capsaicin receptor (TRPV1) near the extracellular side of the S4 transmembrane domain. Biochemistry 2004, 43: 2501–2511. 10.1021/bi035981hPubMedCrossRef
171.
Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, et al.: Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem 2004, 279: 20283–20295. 10.1074/jbc.M312577200PubMedCrossRef
172.
Fernandez-Ballester G, Ferrer-Montiel A: Molecular modeling of the full-length human TRPV1 channel in closed and desensitized states. J Membr Biol 2008, 223: 161–172. 10.1007/s00232-008-9123-7PubMedCrossRef
173.
Johnson DM, Garrett EM, Rutter R, Bonnert TP, Gao YD, Middleton RE, Sutton KG: Functional mapping of the transient receptor potential vanilloid 1 intracellular binding site. Mol Pharmacol 2006, 70: 1005–1012. 10.1124/mol.106.023945PubMedCrossRef
174.
Numazaki M, Tominaga T, Toyooka H, Tominaga M: Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 2002, 277: 13375–13378. 10.1074/jbc.C200104200PubMedCrossRef
175.
Susankova K, Ettrich R, Vyklicky L, Teisinger J, Vlachova V: Contribution of the putative inner-pore region to the gating of the transient receptor potential vanilloid subtype 1 channel (TRPV1). J Neurosci 2007, 27: 7578–7585. 10.1523/JNEUROSCI.1956-07.2007PubMedCrossRef
176.
Mohapatra DP, Wang SY, Wang GK, Nau C: A tyrosine residue in TM6 of the Vanilloid Receptor TRPV1 involved in desensitization and calcium permeability of capsaicin-activated currents. Mol Cell Neurosci 2003, 23: 314–324. 10.1016/S1044-7431(03)00054-XPubMedCrossRef
177.
Myers BR, Bohlen CJ, Julius D: A yeast genetic screen reveals a critical role for the pore helix domain in TRP channel gating. Neuron 2008, 58: 362–373. 10.1016/j.neuron.2008.04.012PubMedCentralPubMedCrossRef
178.
Salazar H, Jara-Oseguera A, Hernandez-Garcia E, Llorente I, Arias O II, Soriano-Garcia M, Islas LD, Rosenbaum T: Structural determinants of gating in the TRPV1 channel. Nat Struct Mol Biol 2009, 16: 704–710. 10.1038/nsmb.1633PubMedCrossRef
179.
Boukalova S, Marsakova L, Teisinger J, Vlachova V: Conserved residues within the putative S4-S5 region serve distinct functions among thermosensitive vanilloid transient receptor potential (TRPV) channels. J Biol Chem 2010, 285: 41455–41462. 10.1074/jbc.M110.145466PubMedCentralPubMedCrossRef
180.
Lee JH, Lee Y, Ryu H, Kang DW, Lee J, Lazar J, Pearce LV, Pavlyukovets VA, Blumberg PM, Choi S: Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies. J Comput Aided Mol Des 2011, 25: 317–327. 10.1007/s10822-011-9421-5PubMedCentralPubMedCrossRef
181.
Bautista DM, Movahed P, Hinman A, Axelsson HE, Sterner O, Hogestatt ED, Julius D, Jordt SE, Zygmunt PM: Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci U S A 2005, 102: 12248–12252. 10.1073/pnas.0505356102PubMedCentralPubMedCrossRef
182.
Hinman A, Chuang HH, Bautista DM, Julius D: TRP channel activation by reversible covalent modification. Proc Natl Acad Sci U S A 2006, 103: 19564–19568. 10.1073/pnas.0609598103PubMedCentralPubMedCrossRef
183.
Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, Patapoutian A: Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41: 849–857. 10.1016/S0896-6273(04)00150-3PubMedCrossRef
184.
Macpherson LJ, Dubin AE, Evans MJ, Marr F, Schultz PG, Cravatt BF, Patapoutian A: Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007, 445: 541–545. 10.1038/nature05544PubMedCrossRef
185.
Rosenbaum T, Castanares DT, Lopez-Valdes HE, Hiriart M: Nerve growth factor increases L-type calcium current in pancreatic beta cells in culture. J Membr Biol 2002, 186: 177–184. 10.1007/s00232-001-0143-9PubMedCrossRef
186.
Salazar H, Llorente I, Jara-Oseguera A, Garcia-Villegas R, Munari M, Gordon SE, Islas LD, Rosenbaum T: A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic. Nat Neurosci 2008, 11: 255–261. 10.1038/nn2056PubMedCentralPubMedCrossRef
187.
Latorre R, Zaelzer C, Brauchi S: Structure-functional intimacies of transient receptor potential channels. Q Rev Biophys 2009, 42: 201–246. 10.1017/S0033583509990072PubMedCrossRef
188.
Brauchi S, Orta G, Salazar M, Rosenmann E, Latorre R: A hot-sensing cold receptor: C-terminal domain determines thermosensation in transient receptor potential channels. J Neurosci 2006, 26: 4835–4840. 10.1523/JNEUROSCI.5080-05.2006PubMedCrossRef
189.
Yao J, Liu B, Qin F: Modular thermal sensors in temperature-gated transient receptor potential (TRP) channels. Proc Natl Acad Sci U S A 2011, 108: 11109–11114. 10.1073/pnas.1105196108PubMedCentralPubMedCrossRef
190.
Cui Y, Yang F, Cao X, Yarov-Yarovoy V, Wang K, Zheng J: Selective disruption of high sensitivity heat activation but not capsaicin activation of TRPV1 channels by pore turret mutations. J Gen Physiol 2012, 139: 273–283. 10.1085/jgp.201110724PubMedCentralPubMedCrossRef
191.
Brauchi S, Orta G, Mascayano C, Salazar M, Raddatz N, Urbina H, Rosenmann E, Gonzalez-Nilo F, Latorre R: Dissection of the components for PIP2 activation and thermosensation in TRP channels. Proc Natl Acad Sci U S A 2007, 104: 10246–10251. 10.1073/pnas.0703420104PubMedCentralPubMedCrossRef
192.
Ryu S, Liu B, Yao J, Fu Q, Qin F: Uncoupling proton activation of vanilloid receptor TRPV1. J Neurosci 2007, 27: 12797–12807. 10.1523/JNEUROSCI.2324-07.2007PubMedCrossRef
193.
Sutton KG, Garrett EM, Rutter AR, Bonnert TP, Jarolimek W, Seabrook GR: Functional characterisation of the S512Y mutant vanilloid human TRPV1 receptor. Br J Pharmacol 2005, 146: 702–711. 10.1038/sj.bjp.0706356PubMedCentralPubMedCrossRef
194.
Grimm C, Aneiros E, de Groot M: Dissecting TRPV1: lessons to be learned? Channels (Austin) 2011, 5: 201–204. 10.4161/chan.5.3.16291CrossRef
195.
Aneiros E, Cao L, Papakosta M, Stevens EB, Phillips S, Grimm C: The biophysical and molecular basis of TRPV1 proton gating. EMBO J 2011, 30: 994–1002. 10.1038/emboj.2011.19PubMedCentralPubMedCrossRef
196.
Voets T, Owsianik G, Janssens A, Talavera K, Nilius B: TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli. Nat Chem Biol 2007, 3: 174–182. 10.1038/nchembio862PubMedCrossRef
197.
Garcia-Martinez C, Morenilla-Palao C, Planells-Cases R, Merino JM, Ferrer-Montiel A: Identification of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties. J Biol Chem 2000, 275: 32552–32558.PubMedCrossRef
198.
Bohlen CJ, Priel A, Zhou S, King D, Siemens J, Julius D: A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain. Cell 2010, 141: 834–845. 10.1016/j.cell.2010.03.052PubMedCentralPubMedCrossRef
199.
Siemens J, Zhou S, Piskorowski R, Nikai T, Lumpkin EA, Basbaum AI, King D, Julius D: Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature 2006, 444: 208–212. 10.1038/nature05285PubMedCrossRef
200.
Kitaguchi T, Swartz KJ: An inhibitor of TRPV1 channels isolated from funnel Web spider venom. Biochemistry 2005, 44: 15544–15549. 10.1021/bi051494lPubMedCrossRef
201.
Grycova L, Lansky Z, Friedlova E, Obsilova V, Janouskova H, Obsil T, Teisinger J: Ionic interactions are essential for TRPV1 C-terminus binding to calmodulin. Biochem Biophys Res Commun 2008, 375: 680–683. 10.1016/j.bbrc.2008.08.094PubMedCrossRef
202.
Grycova L, Lansky Z, Friedlova E, Vlachova V, Kubala M, Obsilova V, Obsil T, Teisinger J: ATP binding site on the C-terminus of the vanilloid receptor. Arch Biochem Biophys 2007, 465: 389–398. 10.1016/j.abb.2007.06.035PubMedCrossRef
203.
Kwon Y, Hofmann T, Montell C: Integration of phosphoinositide- and calmodulin-mediated regulation of TRPC6. Mol Cell 2007, 25: 491–503. 10.1016/j.molcel.2007.01.021PubMedCentralPubMedCrossRef
204.
Zhu MX: Multiple roles of calmodulin and other Ca(2+)-binding proteins in the functional regulation of TRP channels. Pflugers Arch 2005, 451: 105–115. 10.1007/s00424-005-1427-1PubMedCrossRef
205.
Kwak J, Wang MH, Hwang SW, Kim TY, Lee SY, Oh U: Intracellular ATP increases capsaicin-activated channel activity by interacting with nucleotide-binding domains. J Neurosci 2000, 20: 8298–8304.PubMed
206.
Grycova L, Holendova B, Bumba L, Bily J, Jirku M, Lansky Z, Teisinger J: Integrative binding sites within intracellular termini of TRPV1 receptor. PLoS ONE 2012, 7: e48437. 10.1371/journal.pone.0048437PubMedCentralPubMedCrossRef
207.
Tousova K, Susankova K, Teisinger J, Vyklicky L, Vlachova V: Oxidizing reagent copper-o-phenanthroline is an open channel blocker of the vanilloid receptor TRPV1. Neuropharmacology 2004, 47: 273–285. 10.1016/j.neuropharm.2004.04.001PubMedCrossRef
208.
Picazo-Juarez G, Romero-Suarez S, Nieto-Posadas A, Llorente I, Jara-Oseguera A, Briggs M, McIntosh TJ, Simon SA, Ladron-de-Guevara E, Islas LD, Rosenbaum T: Identification of a binding motif in the S5 helix that confers cholesterol sensitivity to the TRPV1 ion channel. J Biol Chem 2011, 286: 24966–24976. 10.1074/jbc.M111.237537PubMedCentralPubMedCrossRef
209.
Numazaki M, Tominaga M: Nociception and TRP Channels. Curr Drug Targets CNS Neurol Disord 2004, 3: 479–485. 10.2174/1568007043336789PubMedCrossRef
210.
Mohapatra DP, Nau C: Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. J Biol Chem 2003, 278: 50080–50090. 10.1074/jbc.M306619200PubMedCrossRef
211.
Zhang X, Huang J, McNaughton PA: NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 2005, 24: 4211–4223. 10.1038/sj.emboj.7600893PubMedCentralPubMedCrossRef
212.
Wirkner K, Hognestad H, Jahnel R, Hucho F, Illes P: Characterization of rat transient receptor potential vanilloid 1 receptors lacking the N-glycosylation site N604. Neuroreport 2005, 16: 997–1001. 10.1097/00001756-200506210-00023PubMedCrossRef
213.
Pecze L, Winter Z, Josvay K, Otvos F, Kolozsi C, Vizler C, Budai D, Letoha T, Dombi G, Szakonyi G, Olah Z: Divalent heavy metal cations block the TRPV1 Ca(2+) channel. Biol Trace Elem Res 2012, 151: 451–461.PubMedCentralPubMedCrossRef
214.
Garcia-Sanz N, Fernandez-Carvajal A, Morenilla-Palao C, Planells-Cases R, Fajardo-Sanchez E, Fernandez-Ballester G, Ferrer-Montiel A: Identification of a tetramerization domain in the C terminus of the vanilloid receptor. J Neurosci 2004, 24: 5307–5314. 10.1523/JNEUROSCI.0202-04.2004PubMedCrossRef
Metadata
Title
Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel – an overview of the current mutational data
Authors
Zoltán Winter
Andrea Buhala
Ferenc Ötvös
Katalin Jósvay
Csaba Vizler
György Dombi
Gerda Szakonyi
Zoltán Oláh
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Molecular Pain / Issue 1/2013
Electronic ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-9-30

Other articles of this Issue 1/2013

Molecular Pain 1/2013 Go to the issue

Research

Voluntary movements as a possible non-reflexive pain assay

Research

TRPV1, but not TRPA1, in primary sensory neurons contributes to cutaneous incision-mediated hypersensitivity

Research

Effect of cholesterol depletion on the pore dilation of TRPV1

Research

Gender, variation in opioid receptor genes and sensitivity to experimental pain

Research

N-type voltage gated calcium channels mediate excitatory synaptic transmission in the anterior cingulate cortex of adult mice

Research

PKCγ receptor mediates visceral nociception and hyperalgesia following exposure to PTSD-like stress in the spinal cord of rats